Johnson & Johnson $JNJ Stock Holdings Trimmed by Quadrant Private Wealth Management LLC

Quadrant Private Wealth Management LLC lessened its position in shares of Johnson & Johnson (NYSE:JNJ) by 4.6% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 22,039 shares of the company’s stock after selling 1,058 shares during the period. Quadrant Private Wealth Management LLC’s holdings in Johnson & Johnson were worth $3,367,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in JNJ. GFG Capital LLC bought a new stake in Johnson & Johnson during the second quarter valued at $35,000. Stone House Investment Management LLC acquired a new position in shares of Johnson & Johnson in the 1st quarter valued at about $47,000. 1248 Management LLC bought a new stake in shares of Johnson & Johnson during the 1st quarter valued at about $48,000. Harvest Fund Management Co. Ltd acquired a new stake in Johnson & Johnson during the first quarter worth about $52,000. Finally, Pandora Wealth Inc. bought a new position in Johnson & Johnson in the first quarter worth about $65,000. 69.55% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on JNJ shares. JPMorgan Chase & Co. increased their price target on Johnson & Johnson from $185.00 to $200.00 and gave the stock a “neutral” rating in a research report on Tuesday, September 16th. Weiss Ratings restated a “buy (b)” rating on shares of Johnson & Johnson in a research note on Friday, October 31st. Daiwa America raised Johnson & Johnson from a “hold” rating to a “strong-buy” rating in a research report on Monday, October 20th. Royal Bank Of Canada reissued an “outperform” rating and set a $209.00 price target on shares of Johnson & Johnson in a report on Friday, October 10th. Finally, Stifel Nicolaus increased their price objective on shares of Johnson & Johnson from $165.00 to $190.00 and gave the stock a “hold” rating in a report on Wednesday, October 15th. Three investment analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and nine have given a Hold rating to the company’s stock. Based on data from MarketBeat, Johnson & Johnson presently has a consensus rating of “Moderate Buy” and an average price target of $199.05.

Insider Activity

In other news, EVP Jennifer L. Taubert sold 56,471 shares of the company’s stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $177.81, for a total value of $10,041,108.51. Following the completion of the sale, the executive vice president owned 178,013 shares in the company, valued at $31,652,491.53. This represents a 24.08% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Company insiders own 0.16% of the company’s stock.

Johnson & Johnson Trading Down 0.3%

NYSE:JNJ opened at $186.50 on Friday. The stock has a market cap of $449.34 billion, a price-to-earnings ratio of 18.00, a PEG ratio of 2.19 and a beta of 0.38. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.80 and a current ratio of 1.07. Johnson & Johnson has a 1 year low of $140.68 and a 1 year high of $194.48. The business has a fifty day moving average of $184.25 and a 200-day moving average of $168.63.

Johnson & Johnson (NYSE:JNJ) last posted its quarterly earnings data on Wednesday, August 30th. The company reported $2.26 earnings per share for the quarter. The business had revenue of $24.02 billion during the quarter. Johnson & Johnson had a net margin of 27.26% and a return on equity of 32.73%. Equities analysts predict that Johnson & Johnson will post 10.58 earnings per share for the current year.

Johnson & Johnson Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 9th. Shareholders of record on Tuesday, November 25th will be paid a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a yield of 2.8%. The ex-dividend date of this dividend is Tuesday, November 25th. Johnson & Johnson’s dividend payout ratio (DPR) is presently 50.19%.

Johnson & Johnson Company Profile

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.